EID Parry (India) Ltd, one of India’s largest sugar manufacturers, reported a 42% decline in consolidated profit after tax (PAT) and non-controlling interest to ₹142 crore for the quarter ended June 30, 2026, compared with ₹246 crore in the corresponding quarter of the previous year.
Consolidated revenue from operations, however, increased 3% to ₹9,017 crore from ₹8,720 crore a year earlier.
EBITDA declined 13% to ₹781 crore from ₹895 crore in Q1 FY26, reflecting pressure across key operating segments.
Sugar operations remain under pressure
The consolidated Sugar & Biofuel division reported a loss before interest and tax (LBIT) of ₹58 crore in Q1 FY27, compared with a loss of ₹30 crore in the year-ago quarter.
Within the sugar segment, revenue rose 18% to ₹410 crore from ₹347 crore, primarily driven by higher sales volumes.
EID Parry (India) Ltd, Whole-time Director and Chief Executive Officer, Muthiah Murugappan, said the higher volumes were not enough to improve profitability as increased operational costs offset the gains.
“Despite the increase in volumes, the segment reported an LBIT of ₹49 crore, which remained at the same level as that of the corresponding quarter of the previous year. The benefits arising from higher sales volumes were offset by increased operational costs, including certain one-time expenses incurred during the quarter,” he said.
Farm Inputs profit moderates
The Farm Inputs division remained the largest contributor to profitability, though its profit before interest and tax declined 12% to ₹649 crore from ₹741 crore in Q1 FY26.
The Distillery segment also saw pressure, with revenue falling 14% to ₹255 crore from ₹296 crore. The decline was primarily attributed to lower offtake of Extra Neutral Alcohol (ENA) by IMFL manufacturers in Tamil Nadu.
Distillery profit fell to ₹9 crore from ₹20 crore, mainly due to lower realisations and higher operational costs.
Nutraceuticals show improvement
The Nutraceuticals division nearly turned around, reporting an LBIT of just ₹0.11 crore, compared with a loss of ₹10 crore in the year-ago quarter.
The improvement was driven by stronger quarterly performance from the company’s US subsidiary, US Nutraceuticals Inc.
The Consumer Products Group (CPG) reported revenue of ₹94 crore, down sharply from ₹188 crore in Q1 FY26. Despite lower revenue, the segment improved its operating margins through a recalibrated operating model and sharper focus on profitability.